Indo US Bio-Tech Stock Price Analysis and Quick Research Report. Is Indo US Bio-Tech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Indo US Bio-Tech. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Indo US Bio-Tech has a PE ratio of 16.11213732204 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Indo US Bio-Tech has ROA of 17.9806% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Indo US Bio-Tech has a Current ratio of 5.308.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Indo US Bio-Tech has a ROE of 23.031%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Indo US Bio-Tech has a Debt to Equity ratio of 0.189 which means that the company has low proportion of debt in its capital.

• Sales growth: Indo US Bio-Tech has reported revenue growth of 42.5641% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Indo US Bio-Tech for the current financial year is 18.236641532574%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Indo US Bio-Tech is Rs 0.25 and the yield is 0.1759%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Indo US Bio-Tech is Rs 8.8784. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Indo US Bio-Tech in Ticker for free. Also, one can get the intrinsic value of Indo US Bio-Tech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Indo US Bio-Tech FAQs

Q1. What is Indo US Bio-Tech share price today?
Ans: The current share price of Indo US Bio-Tech is Rs 143.05.

Q2. What is the market capitalisation of Indo US Bio-Tech?
Ans: Indo US Bio-Tech has a market capitalisation of Rs 286.84386 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Indo US Bio-Tech?
Ans: The PE ratio of Indo US Bio-Tech is 16.11213732204 and the P/B ratio of Indo US Bio-Tech is 3.44675539963569, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Indo US Bio-Tech share?
Ans: The 52-week high share price of Indo US Bio-Tech is Rs 388.4, and the 52-week low share price of Indo US Bio-Tech is Rs 138.13.

Q5. Does Indo US Bio-Tech pay dividends?
Ans: Currently, Indo US Bio-Tech pays dividends. Dividend yield of Indo US Bio-Tech is around 0.1759%.

Q6. What are the face value and book value of Indo US Bio-Tech shares?
Ans: The face value of Indo US Bio-Tech shares is Rs 10, while the book value per share of Indo US Bio-Tech is around Rs 41.5028. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Indo US Bio-Tech?
Ans: Indo US Bio-Tech has a total debt of Rs 14.8362673 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Indo US Bio-Tech?
Ans: The ROE of Indo US Bio-Tech is 23.031% and ROCE of Indo US Bio-Tech is 21.148%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Indo US Bio-Tech a good buy for the long term?
Ans: The Indo US Bio-Tech long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Indo US Bio-Tech undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Indo US Bio-Tech appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Indo US Bio-Tech’s financials?
Ans: You can review Indo US Bio-Tech’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.